Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials-Reference-Cited by-同舟云学术

Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials

Published:2024-04 Issue:4 Volume:6 Page:e226-e236
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Brun Marthe Kirkesæther,Gehin Johanna E,Bjørlykke Kristin Hammersbøen,Warren David John,Klaasen Rolf A,Sexton Joseph,Sandanger Øystein,Kvien Tore K,Mørk Cato,Jahnsen Jørgen,Bolstad Nils,Jørgensen Kristin Kaasen,Haavardsholm Espen A,Goll Guro Løvik,Syversen Silje Watterdal

Publisher

Elsevier BV

Reference31 articles.

1. Discontinuation of biologic therapy due to lack/loss of response and adverse events is similar between TNFi and non-TNFi class: results from a real-world rheumatoid arthritis cohort;Movahedi;Semin Arthritis Rheum,2020

2. Loss of response to anti-TNFs: definition, epidemiology, and management;Roda;Clin Transl Gastroenterol,2016

3. It's like a juggling act: rheumatoid arthritis patient perspectives on daily life and flare while on current treatment regimes;Flurey;Rheumatology (Oxford),2014

4. Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study;Markusse;Arthritis Res Ther,2015

5. Comparative immunogenicity of TNF inhibitors: impact on clinical efficacy and tolerability in the management of autoimmune diseases. A systematic review and meta-analysis;Thomas;BioDrugs,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term follow‐up of immunogenicity in radiographic axial spondyloarthritis patients: beyond drug survival and tapering. Comment on the article by Clarissa et al;Arthritis & Rheumatology;2024-08-23

2. Long‐Term Follow‐Up of Anti‐Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering;Arthritis & Rheumatology;2024-07-14

3. Antidrug Antibody, Therapeutic Drug Monitoring: Status Update and Future Directions in Spondyloarthritis;Arthritis & Rheumatology;2024-07

4. Therapeutic drug monitoring countering the effect of anti-infliximab antibodies;The Lancet Rheumatology;2024-04